affiliation not provided to SSRN
DYRK1A inhibitors, CLK1/CLK4 inhibitors, Targeted therapy, Antiproliferative agents, Heterocycles
α-Aminophosphonate, X-ray diffraction, DFT, Molecular Docking, antimicrobial activity.
Benzophenone-3, In vitro release, lipophilic organosilicates, LAPONITE®, montmorillonite, sunscreen efficacy, rheology